A new method for pharmaceutical compounding and storage of anti-VEGF biologics for intravitreal use in silicone oil-free prefilled plastic syringes

Intravitreal injections of antibody-based biologics targeting vascular endothelial growth factor (VEGF) are highly effective and have markedly decreased the risk of visual impairment associated with prevalent retinal diseases, such as neovascular age-related macular degeneration and diabetes macular...

Descripción completa

Detalles Bibliográficos
Autores principales: Lode, Heidrun Elisabeth, Gjølberg, Torleif Tollefsrud, Foss, Stian, Sivertsen, Magne Sand, Brustugun, Jørgen, Andersson, Yvonne, Jørstad, Øystein Kalsnes, Moe, Morten Carstens, Andersen, Jan Terje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888834/
https://www.ncbi.nlm.nih.gov/pubmed/31792234
http://dx.doi.org/10.1038/s41598-019-54226-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888834/
https://www.ncbi.nlm.nih.gov/pubmed/31792234
http://dx.doi.org/10.1038/s41598-019-54226-7

Ejemplares similares